by Team Small News | Sep 21, 2025 | Lupin, Pharma
The U.S. Food and Drug Administration (FDA) recently conducted an inspection at Lupin’s biotech facility in Pune, India. The inspection, which took place from September 8-19, 2025, was a product-specific pre-approval inspection. As a result of the inspection,... by Team Small News | Sep 19, 2025 | Lupin, Pharma
Lupin Ltd, a global pharmaceutical company, has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules. The approved capsules are available in strengths of 2.5 mg to 25... by Team Small News | Sep 18, 2025 | Lupin, Pharma
Lupin Ltd, a global pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules. The capsules, which will be manufactured at Lupin’s Pithampur facility in...
by Team Small News | Sep 14, 2025 | Aurobindo Pharma, Biocon, Cipla, Glenmark, Lupin, Mankind, Pharma, Sun Pharma, Torrent Pharma, Zydus
The pharmaceutical industry is complex, with various segments such as innovator products, generics, branded generics, and API. Indian companies are making headway globally, and understanding the industry’s intricacies is crucial for those seeking opportunities....
by Team Small News | Sep 8, 2025 | Cipla, Lupin, Mankind, Pharma, Sun Pharma
The Indian pharmaceutical companies, Sun Pharma and Lupin, are developing oral semaglutide pills to address obesity and injection aversion. Currently, leading anti-obesity drugs like Mounjaro and Wegovy are available in injectable form, limiting accessibility and... by Team Small News | Sep 7, 2025 | Lupin, Pharma
Lupin, a pharmaceutical company, has received two observations from the US Food and Drug Administration (USFDA) for its Aurangabad facility. The observations were made during a recent inspection of the facility, which is located in Maharashtra, India. The USFDA...